These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30753800)

  • 1. [Medically Assisted Reproduction in Natural Cycle: Outcome Evaluation of a Reproductive Medicine Department].
    Alves MC; Marques AL; Leite HB; Sousa AP; Almeida-Santos T
    Acta Med Port; 2019 Feb; 32(1):25-29. PubMed ID: 30753800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryo implantation rates in natural and stimulated assisted reproduction treatment cycles in poor responders.
    Ata B; Yakin K; Balaban B; Urman B
    Reprod Biomed Online; 2008 Aug; 17(2):207-12. PubMed ID: 18681994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis.
    Hill MJ; Levens ED; Levy G; Ryan ME; Csokmay JM; DeCherney AH; Whitcomb BW
    Fertil Steril; 2012 May; 97(5):1108-14.e1. PubMed ID: 22365075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The decline in serum estradiol on the second day after oocyte retrieval affects the outcome of IVF/ICSI-ET treatment in high ovarian responders.
    Bai X; Zhang Y; Liu S; Qu D; Su H; Ren H; Li Y
    Gynecol Endocrinol; 2017 Jun; 33(6):452-457. PubMed ID: 28277137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology.
    Yeh JS; Steward RG; Dude AM; Shah AA; Goldfarb JM; Muasher SJ
    Fertil Steril; 2014 Aug; 102(2):399-404. PubMed ID: 24842672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age is a major prognosticator in extremely low oocyte retrieval cycles.
    Su YT; Lin PY; Huang FJ; Kung FT; Lin YJ; Tsai YR; Lan KC
    Taiwan J Obstet Gynecol; 2017 Apr; 56(2):175-180. PubMed ID: 28420503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.
    Chen Q; Wang Y; Sun L; Zhang S; Chai W; Hong Q; Long H; Wang L; Lyu Q; Kuang Y
    Reprod Biol Endocrinol; 2017 Sep; 15(1):71. PubMed ID: 28870217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical outcome of in vitro fertilization or intracytoplasmic sperm injection-embryo transfer in women aged 40 years and above].
    Zhou XY; Feng SX; Li XL; Liu YD; Chen X; Ye DS; Niu J; Chen SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1632-1637. PubMed ID: 27998857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of follicular flushing on reproductive outcomes in patients with poor ovarian response undergoing assisted reproductive technology.
    Souza ALM; Sampaio M; Noronha GB; Coster LGR; de Oliveira RSG; Geber S
    J Assist Reprod Genet; 2017 Oct; 34(10):1353-1357. PubMed ID: 28733801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles.
    Ulug U; Ben-Shlomo I; Turan E; Erden HF; Akman MA; Bahceci M
    Reprod Biomed Online; 2003 Jun; 6(4):439-43. PubMed ID: 12831590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred.
    Gleicher N; Vega MV; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH; Kushnir VA
    Fertil Steril; 2015 Dec; 104(6):1435-41. PubMed ID: 26348275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
    Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
    Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy rates from natural and artificial cycles of women submitted to frozen embryo transfers: a metanalysis.
    Poletto KQ; Lobo MP; Giovanucci M; Approbato MS; Castro EC
    JBRA Assist Reprod; 2019 Aug; 23(3):268-272. PubMed ID: 30912633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Second Follicular Wave Phenomenon in Natural Cycle Assisted Reproduction: A Key Option for Poor Responders through Luteal Phase Oocyte Retrieval.
    Sfakianoudis K; Simopoulou M; Maziotis E; Giannelou P; Tsioulou P; Rapani A; Pantou A; Petroutsou K; Angeli I; Deligeoroglou E; Koutsilieris M; Pantos K
    Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30875815
    [No Abstract]   [Full Text] [Related]  

  • 19. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.
    Polyzos NP; De Vos M; Corona R; Vloeberghs V; Ortega-Hrepich C; Stoop D; Tournaye H
    Hum Reprod; 2013 May; 28(5):1254-60. PubMed ID: 23442756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.